The role of c-myc in regulation of translation initiation
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Translation initiation is important for the regulation of both cell growth and cell division. It is uniquely poised to coordinate overall cell proliferation by its effects on both growth and division. A number of translation initiation factors are transcriptional targets of c-myc in a variety of assays. In particular, the mRNA cap-binding protein eIF4E has a myc-binding sequence in its promoter that is myc responsive in reporter assays and contains a high-affinity myc-binding site in chromosome immunoprecipitation experiments. Several differential expression screens have demonstrated altered levels of eIF4E, along with several other translation initiation factors, in response to alterations of c-myc levels. The potential for eIF4E and other translational control elements to mediate myc's transforming functions is particularly important because eIF4E is itself a known oncogenic factor. The ability of translation initiation factors to affect both cell division control and cell growth control coincides with myc's remarkable effects on both cell growth and cell division.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, MYC is a well-established regulator of ribosome biogenesis and protein translation, including cap-dependent translation, and can rewire translational control in tumor cells when it is overexpressed (29–31).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [30]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
An analysis of vertebrate mRNA sequences: intimations of translational control.
Kozak, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.4.887 · Cited by 1,635
Translational control of gene expression
Sonenberg, N., Hershey, J. W. B., & Mathews, M. B. (2000) · Cold Spring Harbor Laboratory eBooks · Cited by 1,379
Translational control of gene expression
Hannig, E. M. (2001) · BioEssays · doi:10.1002/bies.1108 · Cited by 1,189
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Genomic targets of the human c-Myc protein
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., & Amati, B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 973
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951 · cited 1×
“Those changes include development of resistance to growth inhibition, evasion of apoptosis, immortalization, development of mitogenic independence, acquisition of autologous angiogenic regulation, and development of intrinsic invasive properties (Hanahan and Weinberg, 2000; Hahn and Weinberg, 2002).”
BackgroundDeregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 879
Research works printed but not linked: 2
- Packham G and Cleveland JL . (1994). Mol. Cell. Biol., 14, 5741–5747. · doi:10.1128/mcb.14.9.5741-5747.1994 · Paper page
- Rosenwald IB, Lazaris-Karatzas A, Sonenberg N and Schmidt EV . (1993a). Mol. Cell. Biol., 13, 7358–7363. · doi:10.1128/mcb.13.12.7358-7363.1993 · Paper page
Cited by
Items 101–166 of 166
Desrivières, S., Kuhn, K., Müller, J., Gläser, M., Laria, N. C. P., Korder, J., Sonnentag, M., Neumann, T., Schwarz, J., Schäfer, J., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200600994 · Cited by 23
Stypulkowski, E., Asangani, I. A., & Witze, E. S. (2018) · Science Signaling · doi:10.1126/scisignal.aam8705 · Cited by 23
“A similar abundance in ribosomal proteins is also present in the Myc signature, consistent with its role in driving ribosomal biogenesis and protein translation in the mammary gland, among other tissues, and in cancer (86, 87).”
BackgroundLi, C., Li, W., Cao, S., Xu, J., Qian, Y., Pan, X., Lei, D., & Wei, D. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04346-8 · Cited by 30
“C-Myc regulates expression of many genes by regulating transcription process, including HIF-α [38], eIF4E [39], CDKN1A [40], GLUT1 [41], Bcl-2 [42] and so on.”
BackgroundGaloian, K. A., Temple, T. H., & Galoyan, A. A. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0406-5 · Cited by 22
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
Nardi, F., Perurena, N., Schade, A. E., Li, Z.-H., Ngo, K., Ivanova, E. V., Saldanha, A., Li, C., Gokhale, P. C., Hata, A. N., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167651 · Cited by 21
Regulation of Nucleolar Activity by MYC
Brown, I. N., Lafita‐Navarro, M. C., & Conacci‐Sorrell, M. (2022) · Cells · doi:10.3390/cells11030574 · Cited by 23
“These factors are essential in translation and help carry out this process by binding to the cap structure at the 5′ end of mRNA, initiating the first step in translation [115].”
BackgroundLu, J. N., Lee, W. S., Yun, J. W., Kim, M. J., Kim, H. J., Kim, D. C., Jeong, J., Choi, Y. H., Kim, G. S., Ryu, C. H., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/503043 · Cited by 22
“Many cancer cell lines are resistant to TNF-induced cell death because NFκB enhances the transcription of antiapoptotic proteins that interfere with death signaling [13], and TNF indeed augments cell proliferation in some of the cancer cells [13, 22].”
BackgroundXu, C., Lü, C., Hua, L., Huiming, J., Yin, L., Chen, S., & Qian, R. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70122-9 · Cited by 21
“c-Myc regulates cell growth and proliferation (24).”
Oncogenes as Novel Targets for Cancer Therapy (Part IV): Regulators of the Cell Cycle and Apoptosis
Zhang, Z., Li, M., Rayburn, E. R., Hill, D. L., Zhang, R., & Wang, H. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505060-00006 · Cited by 22
Notch pathway: a bistable inducer of biological noise?
Vujovic, F., Hunter, N., & Farahani, R. H. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0453-0 · Cited by 18
“8S and 28S rRNAs [36], and also RNAPII-mediated transcription of ribosomal proteins [37] together with up-regulation of translation initiation factors [38].”
BackgroundS6 Kinase is essential for MYC-dependent rDNA transcription in Drosophila
Mitchell, N. C., Tchoubrieva, E. B., Chahal, A., Woods, S. J., Lee, A., Lin, J. I., Parsons, L. M., Jastrzebski, K., Poortinga, G., Hannan, K. M., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.018 · Cited by 23
KIM, M. J., Jung, J. H., Lee, W. S., Yun, J. W., Lü, J., Yi, S. M., Kim, H. J., Chang, S., Kim, G. S., Hong, S., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3085 · Cited by 17
Myc in Stem Cell Behaviour: Insights from Drosophila
Quinn, L. M., Secombe, J., & Hime, G. R. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6621-1_15 · Cited by 17
Characterizing Cellular Responses During Oncolytic Maraba Virus Infection
Hassanzadeh, G., Naing, T., Graber, T. E., Jafarnejad, S. M., Stojdl, D. F., Alain, T., & Holčík, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030580 · Cited by 17
Grbčić, P., Čupić, D. F., Gamberi, T., Pavelić, S. K., & Sedić, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126174 · Cited by 14
“Previous studies have shown altered levels of eIF4E in response to changes in the c-Myc levels and provided evidence to support the transcriptional activation of eIF4E by c-Myc [15].”
BackgroundThe Tumor Pathology of Genetically Engineered MiceA New Approach to Molecular Pathology
DCARDIFF, R., JMUNN, R., & JGALVEZ, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50052-2 · Cited by 13
New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer
Yan, L., Wei, W.-Y., Xie, Y.-B., & Xiao, Q. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3960 · Cited by 16
Translation Initiation Factor 4E (eIF4E) is Regulated by Cell Death Inhibitor, Diap1
Lee, S. K., Lee, J. S., Shin, K. S., & Yoo, S. J. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)07363-6 · Cited by 15
Oncogenes as Novel Targets for Cancer Therapy (Part III): Transcription Factors
Zhang, Z., Li, M., Rayburn, E. R., Hill, D. L., Zhang, R., & Wang, H. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505050-00005 · Cited by 12
Control of Ribosomal RNA Transcription by Nutrients
Tanaka, Y., & Tsuneoka, M. (2018) · InTech eBooks · doi:10.5772/intechopen.71866 · Cited by 13
“Therefore, c-Myc activates ribosome biogenesis at multiple steps [3, 44, 45] .”
BackgroundRozhkov, S. V., Sharlo, K. A., Shenkman, B. S., & Mirzoev, T. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052751 · Cited by 11
“Furthermore, c-Myc was shown to be implicated in the transcriptional regulation of a number of ribosomal proteins (including rpS6) and translation initiation factors [42,43].”
BackgroundEpithelial-Mesenchymal Transition and its Regulation in Tumor Metastasis
Sun, T., Qin, Y., & Zhong, W. (2016) · InTech eBooks · doi:10.5772/64497 · Cited by 9
The coordinated management of ribosome and translation during injury and regeneration
Nguyen, T., Mills, J. C., & Cho, C. J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1186638 · Cited by 9
“In addition, numerous c-Myc transcriptional targets are translation initiation factors, such as eIF4E (Schmidt, 2004).”
BackgroundChadburn, A., & Cesarman, E. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_29 · Cited by 10
Mitchell, D. C., Menon, A., & Garner, A. L. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.03.012 · Cited by 12
“We then profiled mRNA expression of several c-Myc target genes (Schmidt, 2004), including NPM1, EIF4E, ODC1 and CDK4, to investigate the functional consequences of diminished c-Myc.”
MethodInterference by interferons: Janus faces in vascular proliferative diseases
Wessely, R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.03.013 · Cited by 9
“c-myc is a proto-oncogene actively involved in cell cycle progression [53] and control of initiation of translation [54].”
BackgroundBorden, K. L. B. (2023) · BioEssays · doi:10.1002/bies.202300145 · Cited by 7
Targeting protein synthesis pathways in MYC-amplified medulloblastoma
Kumar, D., Kanchan, R. K., & Chaturvedi, N. K. (2025) · Discover Oncology · doi:10.1007/s12672-025-01761-7 · Cited by 10
Seibert, M., Koschade, S. E., Stolp, V., Häupl, B., Wempe, F., Serve, H. L., Kurrle, N., Schnütgen, F., & von Metzler, I. (2023) · Cancers · doi:10.3390/cancers15235508 · Cited by 7
“Indeed, this analysis confirms previously determined target pathways of MYC, which are associated with the control of protein synthesis [12,13,29,30].”
BackgroundLiu, B., Wu, Y., Xiang, A.-Y., Yu, Y., Song, S., Zhang, Y., Gu, J., Lu, H., Xu, P., Liu, F., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116249 · Cited by 11
Gao, M., Geng, H., Wu, P., Dong, J., Li, H., Xu, C., Li, B., Han, Y., & Cheng, N. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-301 · Cited by 8
“c-Myc protein is an important DNA-binding protein in the nucleus (20), and its overexpression can cause apoptosis (21).”
BackgroundDiscovery of a Novel MNK Inhibitor (NSP-1047) with In Vivo Anti-acute Myeloid Leukemia Activity
Li, B., Xia, S., Zhang, K., Huang, Q., Chen, Q. K., Wang, J., Wu, D., Zhang, J., Zou, Y., & Zhang, J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00504 · Cited by 6
Nagaraj, S., Stankiewicz-Drogoń, A., Darżynkiewicz, E., Wojda, U., & Grzela, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-54154-1 · Cited by 7
β-Catenin: A Metazoan Filter for Biological Noise?
Rezaei‐Lotfi, S., Hunter, N., & Farahani, R. H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01004 · Cited by 6
“In addition, translation initiation factors, eIF4E, eIF2α, eIF4AI, and eIF4GI, are regulated by transcriptional activity of c-Myc (Schmidt, 2004).”
BackgroundMYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma
Issa, L. H. B., Fléchon, L., Laine, W., Ouelkdite, A., Gaggero, S., Cozzani, A., Tilmont, R., Chauvet, P., Gower, N., Sklavenitis‐Pistofidis, R., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109417 · Cited by 9
Vujovic, F., Shepherd, C. E., Witting, P. K., Hunter, N., & Farahani, R. H. (2023) · Antioxidants · doi:10.3390/antiox12101873 · Cited by 7
“Further, translation initiation factors, eIF4E, eIF2 α , eIF4AI and eIF4GI, are regulated by the transcriptional activity of c-Myc [110].”
BackgroundAdvances in understanding and targeting eIF4E activity
D’Agostino, S., Davies, C., Powers, M. V., & Clarke, P. A. (2025) · Biochemical Society Transactions · doi:10.1042/bst20241045 · Cited by 7
Surya, A., & Cenik, E. S. (2022) · Open Biology · doi:10.1098/rsob.210308 · Cited by 10
Alteraciones del gen c-Myc en la oncogénesis
Pérez, M. O., & Peña, C. M. M. (2012) · IATREIA · doi:10.17533/udea.iatreia.10639 · Cited by 4
“Se conocen cuatro promotores de transcripción, pero el ARN sintetizado a partir del promotor P2 contribuye con 80% a 90% del total del ARN en las células normales (25,26).”
C-Myc misregulation triggers complex process of genomic instability
Marinković, D., & Marinković, T. (2018) · Genetika · doi:10.2298/gensr1802731m · Cited by 4
“…plays significant role in cell growth control, regulation of translation initiation, embryonic vascular permeability and remodeling, metabolism of normal and cancer cells, apoptosis, and hematopoiesis (EVAN and LITTLEWOOD 1993; KOKAI et al., 2009; SCHMIDT, 2004; STINE et al., 2015; THOMPSON, 1998).”
BackgroundCox, R. A., & Arnstein, H. R. V. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200500001 · Cited by 4
Waas, W. F., & Dalby, K. N. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.12.004 · Cited by 3
Jaboticaba Peel Extract Exerts Chemopreventive Effects in Transgenic Mouse Model of Prostate Cancer
Lima, E. N., Lamas, C. D. A., Baseggio, A. M., da Veiga, F. C., Alvares, L. E., Maróstica, M. R., & Cagnon, V. H. A. (2024) · The Natural Products Journal · doi:10.2174/0122103155281770240104091620 · Cited by 2
Genistein-induced proteome changes in the human endometrial carcinoma cell line, ishikawa
Konstantakopoulos, N., Larsen, M. R., Campbell, I., Quinn, M. A., Baker, M. S., Georgiou, H. M., & Rice, G. E. (2006) · Clinical Proteomics · doi:10.1007/bf02752498 · Cited by 2
Comparative multiomics analysis of cell physiological state after culture in a basket bioreactor
Yu, S., Guo, M., Zhang, Y., Bo, C., Liang, H., Wang, H., & Yang, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-24687-4 · Cited by 3
The Tumor Pathology of Genetically Engineered Mice: Genomic Pathology
Cardiff, R. D. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_7 · Cited by 1
Li, M., Duan, Y., Wei, J., Chen, S., Xue, C., Zheng, L., Deng, H., Fan, S., Xiong, W., Li, G., et al. (2023) · PubMed Central · Cited by 4
Modelling the mesenchymal stem cell niche in vitro using magnetic nanoparticles
Lewis, E. E. (2016) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Analyses structurales et fonctionnelles des interactions entre elF4E et ses partenaires
Gosselin, P. (2012) · HAL
Fiancette, R. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
The Biology of MYC in Health and Disease: A High Altitude View
Turner, B. C., Bird, G. A., & Refaeli, Y. (2010) · Wiley eBooks · doi:10.1002/9783527630332.ch1
Regulation of Translation in Malignant Transformation
Clemens, M. J. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap222
Carlson, J. H. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Oulhen, N., & CORMIER, P. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Romero, C. M. (2009) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Sanz, A. B. C. (2017) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.48607
LncRNA PVT1 Associates with c-Myc and Stabilizes Oncogenic Signaling in Prostate Cancer
Jones, R. L. (2017) · UA Campus Repository (The University of Arizona) · Cited by 1
Investigating the role of mRNA capping enzyme in C-MYC function
Lombardi, O. (2017) · Discovery Research Portal (University of Dundee)
Myc-family oncogenes as therapeutic targets
Kabilova, T. O., & Chernolovskaya, Y. L. (2008) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2008-0-11-25
RPL34 regulates osteosarcoma cells proliferation through c-Myc/RPL34 signaling axisPreprint
Huang, P., Wei, M., Ji, S.-F., Fowdur, M., & He, M. (2021) · Research Square · doi:10.21203/rs.3.rs-1088745/v1
Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H. S., Recht, L. D., & Sikic, B. I. (2023) · doi:10.1158/0008-5472.c.6494648
Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H. S., Recht, L. D., & Sikic, B. I. (2023) · doi:10.1158/0008-5472.c.6494648.v1
Duan, Y., Zhou, X., Wei, J., Xue, C., Zheng, L., Zeng, T., Deng, H., Fan, S., Xiong, W., Zhou, M., et al. (2026) · Cancers · doi:10.3390/cancers18203257
Molecular mechanisms involved in oligodendrocyte development
Coelho, R. P. (2008) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/fx70-ha31
“Binding of the eIF4F complex to the mRNA is mediated by its cap-binding subunit eIF4E (Gingras et al. 1999), a factor that is normally maintained at limiting levels by controlled gene transcription (Lynch et al. 2005; Schmidt 2004) and proteosome-dependent degradation (Murata and Shimotohno 2006).”
Background
Metadata
- Authors
- Schmidt, E. V.
- Affiliations
- Harvard University (US)
- Corresponding author
- Schmidt, Emmett V
- ORCID
- Schmidt, Emmett V
- Venue
- Oncogene
- Published
- 2004-04-19
- Volume
- 23
- Issue
- 18
- Pages
- 3217-3221
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1995431293
- Cited by
- 166
- References
- 63
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 9 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 12 · 2014: 7 · 2013: 11 · 2012: 8
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA063117)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- c-Myc, translation initiation, eIF4E, translation initiation factors, mRNA cap-binding protein, transcriptional regulation, cell proliferation, cell growth regulation, cell division regulation, oncogenic transformation, translational regulation
- MeSH terms
- Animals, Carrier Proteins, Cell Division, Cell Transformation, Neoplastic, Humans, Phosphoproteins, Protein Biosynthesis, Proto-Oncogene Proteins c-myc, Cell Cycle Proteins, Eukaryotic Initiation Factor-4E, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.